Steven Helper, a senior vice president of equity research who covers the healthcare sector for FBR Capital Markets, a subsidiary of FBR & Co. in New York, told Institutional Investor he sees a slowdown in the healthcare market in 2015 due to a payment rate cuts to Medicare Advantage plans, “which have presented a delicate political balance,” according to the report.
However, medical device companies are likely to do well under a Republican-led Congress, according to the report. That is because Republicans are likely to try to repeal the 2.3 percent tax on revenues from medical devices. The tax has been in effect since Jan. 1, 2013.
More articles on healthcare finance:
Are CEOs setting the bar too high for CFOs?
Seattle Children’s Hospital to use $54M from bond issuance for capital expenditures
3 themes for healthcare investments in 2015
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
